|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 177.95 CNY | +7.63% |
|
+16.23% | +91.49% |
Company Valuation: Asymchem Laboratories (Tianjin) Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 111,228 | 52,704 | 41,387 | 26,238 | 32,605 | 62,129 | - | - |
| Change | - | -52.62% | -21.47% | -36.6% | 24.27% | 90.55% | - | - |
| Enterprise Value (EV) 1 | 105,383 | 47,524 | 34,318 | 20,491 | 26,337 | 57,050 | 57,723 | 58,303 |
| Change | - | -54.9% | -27.79% | -40.29% | 28.53% | 116.61% | 1.18% | 1% |
| P/E | 99.1x | 16.4x | 18.5x | 28.3x | 29.4x | 45.6x | 36.8x | 28.1x |
| PBR | 9.07x | 3.5x | 2.46x | 1.66x | 1.9x | 3.42x | 3.21x | 2.96x |
| PEG | - | 0x | -0.6x | -0.5x | 1.7x | 1.9x | 1.5x | 0.9x |
| Capitalization / Revenue | 24x | 5.15x | 5.29x | 4.52x | 4.89x | 7.69x | 6.41x | 5.36x |
| EV / Revenue | 22.7x | 4.65x | 4.39x | 3.53x | 3.95x | 7.07x | 5.96x | 5.03x |
| EV / EBITDA | 75.3x | 13.6x | 11.2x | 16.1x | 15.1x | 26.6x | 22.2x | 18.3x |
| EV / EBIT | 88.4x | 15.2x | 13.3x | 19x | 22.5x | 35.9x | 28.9x | 22.5x |
| EV / FCF | -68.1x | 41.8x | 14.6x | 164x | 192x | -97.5x | 65.6x | 46x |
| FCF Yield | -1.47% | 2.39% | 6.84% | 0.61% | 0.52% | -1.03% | 1.52% | 2.18% |
| Dividend per Share 2 | 0.5714 | 1.8 | 1.8 | 1.1 | 1.3 | 1.48 | 1.778 | 2.081 |
| Rate of return | 0.18% | 1.22% | 1.55% | 1.45% | 1.4% | 0.83% | 1% | 1.17% |
| EPS 2 | 3.136 | 9 | 6.26 | 2.69 | 3.16 | 3.902 | 4.838 | 6.328 |
| Distribution rate | 18.2% | 20% | 28.8% | 40.9% | 41.1% | 37.9% | 36.8% | 32.9% |
| Net sales 1 | 4,639 | 10,230 | 7,825 | 5,805 | 6,670 | 8,075 | 9,688 | 11,599 |
| EBITDA 1 | 1,399 | 3,498 | 3,058 | 1,274 | 1,744 | 2,143 | 2,598 | 3,188 |
| EBIT 1 | 1,192 | 3,136 | 2,571 | 1,079 | 1,169 | 1,589 | 1,997 | 2,590 |
| Net income 1 | 1,069 | 3,302 | 2,269 | 949 | 1,133 | 1,407 | 1,763 | 2,285 |
| Net Debt 1 | -5,846 | -5,180 | -7,069 | -5,747 | -6,268 | -5,079 | -4,405 | -3,825 |
| Reference price 2 | 310.71 | 148.00 | 116.10 | 76.09 | 92.93 | 177.95 | 177.95 | 177.95 |
| Nbr of stocks (in thousands) | 368,307 | 364,755 | 364,426 | 354,879 | 359,442 | 359,724 | - | - |
| Announcement Date | 3/30/22 | 3/30/23 | 3/28/24 | 3/28/25 | 3/30/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 45.61x | 7.07x | 26.62x | 0.83% | 9.17B | ||
| 34.25x | 12.25x | 25.43x | 0.59% | 1,028B | ||
| 27.09x | 6.22x | 16.9x | 2.1% | 611B | ||
| 30.33x | 7.27x | 14.9x | 2.81% | 432B | ||
| 17.47x | 4.34x | 10.68x | 3.06% | 323B | ||
| 21.17x | 5.44x | 13.17x | 2.9% | 277B | ||
| 20.69x | 4.37x | 12.08x | 2.02% | 257B | ||
| 13.99x | 5.26x | 10.84x | 3.55% | 217B | ||
| 23.3x | 6.19x | 10.94x | 2.84% | 192B | ||
| -46.85x | 5.61x | 31x | 2.5% | 161B | ||
| Average | 18.71x | 6.40x | 17.26x | 2.32% | 350.75B | |
| Weighted average by Cap. | 23.40x | 7.66x | 17.91x | 2.04% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 002821 Stock
- Valuation Asymchem Laboratories (Tianjin) Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
















